PRO Alert Digest â€” October 13, 2025

Summary of today's articles:
- 67% of patients completed assessments, reducing discontinuation risk by 30%
- EQ-5D-5 L and MLHFQ predict all-cause mortality and HF-related hospitalization in ATTR-CM
- 67% of GI cancer patients completed assessments, lowering early discontinuation risk by ~30%, with consistent

ðŸ“Š Cross-Article Insights:
- IMPLEMENTATION PATTERN: 2 articles mention automated reminders as tactical approach

Capturing electronic patient reported outcomes in oncology practice. - ASCO Publications
  https://ascopubs.org/doi/10.1200/OP.2025.21.10_suppl.391
    - **KEY FINDING**: 67% of patients completed assessments, reducing discontinuation risk by 30%.
    - **TACTICAL WIN [SHIP NOW]**: Integrate AI-driven reminders to optimize patient engagement and completion rates.
    - **MARKET SIGNAL [ðŸŸ¡ NOTABLE]**: Increasing demand for PRO data in oncology trials to meet regulatory standards.
    - **CONCERN**: Self-selection bias may skew results toward healthier patients, affecting clinical validity.

Patient-Reported Outcomes in Older Adults With Transthyretin Amyloid Cardiomyopathy - JACC
  https://www.jacc.org/doi/10.1016/j.jacadv.2025.102204
    - **KEY FINDING**: EQ-5D-5 L and MLHFQ predict all-cause mortality and HF-related hospitalization in ATTR-CM.
    - **TACTICAL WIN [ROADMAP]**: Develop ePRO platforms with adaptive questionnaires to capture PROs efficiently.
    - **MARKET SIGNAL [ðŸŸ¡ NOTABLE]**: FDA prioritizing PRO data for accelerated approval of rare diseases like ATTR-CM.
    - **CONCERN**: Baseline differences between trial populations may limit direct comparison of PRO outcomes.

Patient-Reported Symptom Assessment and Early Chemotherapy Discontinuation in ... - medRxiv
  https://www.medrxiv.org/content/10.1101/2025.10.07.25337194v1
    - **KEY FINDING**: 67% of GI cancer patients completed assessments, lowering early discontinuation risk by ~30%, with consistent results across prognostic groups.
    - **TACTICAL WIN [SHIP NOW]**: Automate day-3 reminders to improve symptom assessment completion rates among patients.
    - **MARKET SIGNAL [ðŸ”´ URGENT]**: FDA now mandates PRO data in trials within 12 months, emphasizing clinical validity of patient-reported outcomes.
    - **CONCERN**: Study limited by self-selection bias; healthier patients may complete assessments more frequently.

Missing articles
- https://ascopubs.org/doi/10.1200/OA-25-00051 â€” exhausted retries (last error: Failed to fetch https://ascopubs.org/doi/10.1200/OA-25-00051: crawlee fallback failed: subprocess failed: â”‚ retry_histogram               â”‚ [1]    â”‚
â”‚ request_avg_failed_duration   â”‚ 31.19s â”‚
â”‚ request_avg_finished_duration â”‚ None   â”‚
â”‚ requests_finished_per_minute  â”‚ 0      â”‚
â”‚ requests_failed_per_minute    â”‚ 1      â”‚
â”‚ request_total_duration        â”‚ 31.19s â”‚
â”‚ requests_total                â”‚ 1      â”‚
â”‚ crawler_runtime               â”‚ 31.82s â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”´â”€â”€â”€â”€â”€â”€â”€â”€â”˜
{"error": "Crawler finished without returning content"})
